Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages e068373
Publisher
BMJ
Online
2022-03-17
DOI
10.1136/bmj-2021-068373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANA Investigates: Neurological Complications of COVID ‐19 Vaccines
- (2021) Adeline L. Goss et al. ANNALS OF NEUROLOGY
- Viral infections and their relationship to neurological disorders
- (2021) Jéssica Wouk et al. ARCHIVES OF VIROLOGY
- Guillain- Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality
- (2021) Alejandra M Márquez Loza et al. NEUROLOGY
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Facial Paralysis With mRNA COVID-19 Vaccines
- (2021) Lucie Renoud et al. JAMA Internal Medicine
- Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)
- (2021) Gustavo C. Román et al. Frontiers in Immunology
- Postvaccinal Encephalitis after ChAdOx1 nCov ‐19
- (2021) Frédéric Zuhorn et al. ANNALS OF NEUROLOGY
- Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination
- (2021) Alberto Vogrig et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Surveillance for Adverse Events After COVID-19 mRNA Vaccination
- (2021) Nicola P. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
- (2021) Eric Yuk Fai Wan et al. LANCET INFECTIOUS DISEASES
- Guillain‐Barré syndrome after COVID‐19 mRNA vaccination in a liver transplant recipient with favorable treatment response
- (2021) Dempsey L. Hughes et al. LIVER TRANSPLANTATION
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bell’s palsy following the Ad26.COV2.S COVID-19 vaccination
- (2021) Y Nishizawa et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Avoiding bias in self‐controlled case series studies of coronavirus disease 2019
- (2021) Osvaldo Fonseca‐Rodríguez et al. STATISTICS IN MEDICINE
- Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
- (2021) Xintong Li et al. BMJ-British Medical Journal
- COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect
- (2021) Ahmad S. Matarneh et al. Clinical Case Reports
- Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar
- (2021) Almurtada Razok et al. Annals of Medicine and Surgery
- Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database
- (2021) Kenichiro Sato et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021
- (2021) Emily Jane Woo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
- (2021) Martina Patone et al. NATURE MEDICINE
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- (2020) Ross W Paterson et al. BRAIN
- Oxford–AstraZeneca COVID-19 vaccine efficacy
- (2020) Maria Deloria Knoll et al. LANCET
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
- (2019) Achim Wolf et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Self controlled case series methods: an alternative to standard epidemiological study designs
- (2016) Irene Petersen et al. BMJ-British Medical Journal
- Self controlled case series methods: an alternative to standard epidemiological study designs
- (2016) Irene Petersen et al. BMJ-British Medical Journal
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study
- (2014) Alastair J S Webb et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Massive Parallelization of Serial Inference Algorithms for a Complex Generalized Linear Model
- (2013) Marc A. Suchard et al. ACM Transactions on Modeling and Computer Simulation
- Investigation of the Temporal Association of Guillain-Barre Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database
- (2008) J. Stowe et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started